Tri-point Medical's topical wound sealant, TraumaSeal, has completed a 819-patient trial at ten US sites. The trial compared the sealant to surgical sutures for treating wounds and the results are being compiled by the Biometric Research Institute in Arlington, Virginia, for a PMA submission to the FDA early next year. Tri-Point, based in Raleigh, North Carolina, estimates that nearly 45 million wound closure procedures are conducted each year in the US, with the vast majority using surgical sutures.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?